Gerald Arthur

Title: Innovations of Gerald Arthur in Peptide Technology

Introduction

Gerald Arthur is an accomplished inventor based in Rocheport, MO (US). He has made significant contributions to the field of peptide technology, particularly in the development of peptides with specific binding affinities.

Latest Patents

Gerald Arthur holds a patent for a peptide with gold binding and EGFR receptor affinity, which is attached to a gold nanostructure. This invention includes a peptide comprising four domains, where domain I consists of thioctyl or monocytl, domain II consists of 2 to 3 positively charged amino acids selected from lysine and arginine, domain III consists of a dimeric ethylene unit, and domain IV comprises the peptide with SEQ ID No. 1 or a sequence having at least 90% identity to SEQ ID No. 1. The peptide is preferably attached to a gold nanostructure, specifically a gold nanorod, to provide an EGFR detection kit. This kit employs a gold nanostructure attached to a peptide sequence that includes a binding sequence with an affinity toward EGFR, a ligand bound to gold atoms of the nanorod, a positively charged amino acid that maintains the activity of the binding sequence, and a unit that increases the hydrophilicity of the peptide sequence. Gerald Arthur has 1 patent to his name.

Career Highlights

Gerald Arthur is affiliated with the University of Missouri, where he continues to advance his research in peptide technology. His work has implications for various applications, particularly in the medical field.

Collaborations

Some of his notable coworkers include Charles W Caldwell, Jr. and Raghuraman Kannan, who have contributed to his research endeavors.

Conclusion

Gerald Arthur's innovative work in peptide technology showcases his expertise and commitment to advancing scientific knowledge. His contributions are paving the way for future developments in the field.